{"entity":{"type":"insider","cik":"0001514588","url":"/insider/0001514588","json_url":"/insider/0001514588.json","name":"Havey Adam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":22,"first":"2011-03-15","last":"2021-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Havey Adam","source":"filing","n_filings":22,"first_seen":"2011-03-15","last_seen":"2021-03-03"}],"transactions":[{"id":4444933,"accession":"0001367644-21-000049","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-21-000049","line_url":"/filing/0001367644-21-000049#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20145.0,"shares_display":"20,145","price_per_share":99.02,"price_display":"99.02","price_state":"stated","total_value":1994757.9,"total_display":"1,994,757.90","shares_owned_after":38190.0,"shares_owned_after_display":"38,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":4444928,"accession":"0001367644-21-000049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001367644-21-000049","line_url":"/filing/0001367644-21-000049#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17134.0,"shares_display":"17,134","price_per_share":99.62,"price_display":"99.62","price_state":"stated","total_value":1706889.08,"total_display":"1,706,889.08","shares_owned_after":38190.0,"shares_owned_after_display":"38,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2060415,"accession":"0001367644-20-000037","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001367644-20-000037","line_url":"/filing/0001367644-20-000037#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17009.0,"shares_display":"17,009","price_per_share":69.0,"price_display":"69.00","price_state":"stated","total_value":1173621.0,"total_display":"1,173,621.00","shares_owned_after":34256.0,"shares_owned_after_display":"34,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-20","filed_date":"2020-04-21","scope":"insider"},{"id":2060412,"accession":"0001367644-20-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-20-000037","line_url":"/filing/0001367644-20-000037#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20414.0,"shares_display":"20,414","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":1326910.0,"total_display":"1,326,910.00","shares_owned_after":34256.0,"shares_owned_after_display":"34,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-17","filed_date":"2020-04-21","scope":"insider"},{"id":2607504,"accession":"0001367644-20-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001367644-20-000035","line_url":"/filing/0001367644-20-000035#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4242.0,"shares_display":"4,242","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":254520.0,"total_display":"254,520.00","shares_owned_after":37986.0,"shares_owned_after_display":"37,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-06","filed_date":"2020-04-08","scope":"insider"},{"id":2607500,"accession":"0001367644-20-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001367644-20-000035","line_url":"/filing/0001367644-20-000035#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3730.0,"shares_display":"3,730","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":223800.0,"total_display":"223,800.00","shares_owned_after":34256.0,"shares_owned_after_display":"34,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-06","filed_date":"2020-04-08","scope":"insider"},{"id":8630919,"accession":"0001567619-19-006788","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-006788","line_url":"/filing/0001567619-19-006788#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2430.0,"shares_display":"2,430","price_per_share":56.93,"price_display":"56.93","price_state":"stated","total_value":138339.9,"total_display":"138,339.90","shares_owned_after":32240.0,"shares_owned_after_display":"32,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-11","filed_date":"2019-03-13","scope":"insider"},{"id":8768740,"accession":"0001567619-19-006067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-006067","line_url":"/filing/0001567619-19-006067#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2024.0,"shares_display":"2,024","price_per_share":58.2,"price_display":"58.20","price_state":"stated","total_value":117796.8,"total_display":"117,796.80","shares_owned_after":34670.0,"shares_owned_after_display":"34,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider"},{"id":8768739,"accession":"0001567619-19-006067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-006067","line_url":"/filing/0001567619-19-006067#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1019.0,"shares_display":"1,019","price_per_share":57.9218,"price_display":"57.92","price_state":"stated","total_value":59022.3142,"total_display":"59,022.31","shares_owned_after":36694.0,"shares_owned_after_display":"36,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-28","filed_date":"2019-03-04","scope":"insider"},{"id":6315426,"accession":"0001567619-18-005093","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-18-005093","line_url":"/filing/0001567619-18-005093#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6168.0,"shares_display":"6,168","price_per_share":64.5,"price_display":"64.50","price_state":"stated","total_value":397836.0,"total_display":"397,836.00","shares_owned_after":29253.0,"shares_owned_after_display":"29,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-05","scope":"insider"},{"id":6315415,"accession":"0001567619-18-005093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-005093","line_url":"/filing/0001567619-18-005093#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2011.0,"shares_display":"2,011","price_per_share":63.5,"price_display":"63.50","price_state":"stated","total_value":127698.5,"total_display":"127,698.50","shares_owned_after":29253.0,"shares_owned_after_display":"29,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider"},{"id":9291835,"accession":"0001567619-18-004474","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-004474","line_url":"/filing/0001567619-18-004474#line-1","is_derivative":false,"issuer_cik":"0001514588","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001514588","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":314.0,"shares_display":"314","price_per_share":63.5,"price_display":"63.50","price_state":"stated","total_value":19939.0,"total_display":"19,939.00","shares_owned_after":29253.0,"shares_owned_after_display":"29,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-17","filed_date":"2018-10-24","scope":"insider"},{"id":6402655,"accession":"0001567619-18-004358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-004358","line_url":"/filing/0001567619-18-004358#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":314.0,"shares_display":"314","price_per_share":61.5,"price_display":"61.50","price_state":"stated","total_value":19311.0,"total_display":"19,311.00","shares_owned_after":29253.0,"shares_owned_after_display":"29,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-17","filed_date":"2018-10-19","scope":"insider"},{"id":6798149,"accession":"0001567619-18-004223","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001567619-18-004223","line_url":"/filing/0001567619-18-004223#line-9","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6165.0,"shares_display":"6,165","price_per_share":61.5,"price_display":"61.50","price_state":"stated","total_value":379147.5,"total_display":"379,147.50","shares_owned_after":29253.0,"shares_owned_after_display":"29,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-16","filed_date":"2018-10-17","scope":"insider"},{"id":6798146,"accession":"0001567619-18-004223","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001567619-18-004223","line_url":"/filing/0001567619-18-004223#line-8","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3840.0,"shares_display":"3,840","price_per_share":63.5,"price_display":"63.50","price_state":"stated","total_value":243840.0,"total_display":"243,840.00","shares_owned_after":29253.0,"shares_owned_after_display":"29,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-16","filed_date":"2018-10-17","scope":"insider"},{"id":6798139,"accession":"0001567619-18-004223","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001567619-18-004223","line_url":"/filing/0001567619-18-004223#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6165.0,"shares_display":"6,165","price_per_share":60.1549,"price_display":"60.15","price_state":"stated","total_value":370854.9585,"total_display":"370,854.96","shares_owned_after":29914.0,"shares_owned_after_display":"29,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-17","scope":"insider"},{"id":6798136,"accession":"0001567619-18-004223","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-18-004223","line_url":"/filing/0001567619-18-004223#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6165.0,"shares_display":"6,165","price_per_share":60.0293,"price_display":"60.03","price_state":"stated","total_value":370080.6345,"total_display":"370,080.63","shares_owned_after":29914.0,"shares_owned_after_display":"29,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-17","scope":"insider"},{"id":6798132,"accession":"0001567619-18-004223","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-18-004223","line_url":"/filing/0001567619-18-004223#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":661.0,"shares_display":"661","price_per_share":60.67,"price_display":"60.67","price_state":"stated","total_value":40102.87,"total_display":"40,102.87","shares_owned_after":29253.0,"shares_owned_after_display":"29,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-17","scope":"insider"},{"id":6627758,"accession":"0001140361-18-013317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-013317","line_url":"/filing/0001140361-18-013317#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5842.0,"shares_display":"5,842","price_per_share":52.82,"price_display":"52.82","price_state":"stated","total_value":308574.44,"total_display":"308,574.44","shares_owned_after":29914.0,"shares_owned_after_display":"29,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-13","scope":"insider"},{"id":6734931,"accession":"0001140361-18-011285","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-18-011285","line_url":"/filing/0001140361-18-011285#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1898.0,"shares_display":"1,898","price_per_share":49.5,"price_display":"49.50","price_state":"stated","total_value":93951.0,"total_display":"93,951.00","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-01","scope":"insider"},{"id":4173068,"accession":"0001140361-17-036981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-036981","line_url":"/filing/0001140361-17-036981#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7885.0,"shares_display":"7,885","price_per_share":39.5,"price_display":"39.50","price_state":"stated","total_value":311457.5,"total_display":"311,457.50","shares_owned_after":26046.0,"shares_owned_after_display":"26,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-27","filed_date":"2017-09-29","scope":"insider"},{"id":5246721,"accession":"0001140361-17-035190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-035190","line_url":"/filing/0001140361-17-035190#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Business Operations)","officer_title":"EVP, Business Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7885.0,"shares_display":"7,885","price_per_share":37.0631,"price_display":"37.06","price_state":"stated","total_value":292242.5435,"total_display":"292,242.54","shares_owned_after":26046.0,"shares_owned_after_display":"26,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-08","filed_date":"2017-09-12","scope":"insider"},{"id":5140585,"accession":"0001140361-17-014647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-014647","line_url":"/filing/0001140361-17-014647#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11419.0,"shares_display":"11,419","price_per_share":28.6197,"price_display":"28.62","price_state":"stated","total_value":326808.3543,"total_display":"326,808.35","shares_owned_after":26046.0,"shares_owned_after_display":"26,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-04","scope":"insider"},{"id":4786922,"accession":"0001140361-17-002340","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-002340","line_url":"/filing/0001140361-17-002340#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8438.0,"shares_display":"8,438","price_per_share":29.7465,"price_display":"29.75","price_state":"stated","total_value":251000.967,"total_display":"251,000.97","shares_owned_after":34333.0,"shares_owned_after_display":"34,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-19","scope":"insider"},{"id":2086851,"accession":"0001140361-16-058008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-058008","line_url":"/filing/0001140361-16-058008#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2701.0,"shares_display":"2,701","price_per_share":33.96,"price_display":"33.96","price_state":"stated","total_value":91725.96,"total_display":"91,725.96","shares_owned_after":39163.0,"shares_owned_after_display":"39,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-14","filed_date":"2016-03-16","scope":"insider"},{"id":2086848,"accession":"0001140361-16-058008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-058008","line_url":"/filing/0001140361-16-058008#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1658.0,"shares_display":"1,658","price_per_share":33.96,"price_display":"33.96","price_state":"stated","total_value":56305.68,"total_display":"56,305.68","shares_owned_after":37505.0,"shares_owned_after_display":"37,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-14","filed_date":"2016-03-16","scope":"insider"},{"id":3183105,"accession":"0001140361-16-057803","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-16-057803","line_url":"/filing/0001140361-16-057803#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7960.0,"shares_display":"7,960","price_per_share":33.84,"price_display":"33.84","price_state":"stated","total_value":269366.4,"total_display":"269,366.40","shares_owned_after":46294.0,"shares_owned_after_display":"46,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-11","filed_date":"2016-03-15","scope":"insider"},{"id":3183100,"accession":"0001140361-16-057803","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-057803","line_url":"/filing/0001140361-16-057803#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3152.0,"shares_display":"3,152","price_per_share":33.84,"price_display":"33.84","price_state":"stated","total_value":106663.68,"total_display":"106,663.68","shares_owned_after":43142.0,"shares_owned_after_display":"43,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-11","filed_date":"2016-03-15","scope":"insider"},{"id":8646547,"accession":"0001140361-15-024569","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-15-024569","line_url":"/filing/0001140361-15-024569#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15919.0,"shares_display":"15,919","price_per_share":31.502,"price_display":"31.50","price_state":"stated","total_value":501480.338,"total_display":"501,480.34","shares_owned_after":41444.0,"shares_owned_after_display":"41,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-17","scope":"insider"},{"id":8646545,"accession":"0001140361-15-024569","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-15-024569","line_url":"/filing/0001140361-15-024569#line-4","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10606.0,"shares_display":"10,606","price_per_share":31.502,"price_display":"31.50","price_state":"stated","total_value":334110.212,"total_display":"334,110.21","shares_owned_after":30838.0,"shares_owned_after_display":"30,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-17","scope":"insider"},{"id":8646543,"accession":"0001140361-15-024569","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-024569","line_url":"/filing/0001140361-15-024569#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9773.0,"shares_display":"9,773","price_per_share":31.665,"price_display":"31.66","price_state":"stated","total_value":309462.045,"total_display":"309,462.04","shares_owned_after":41444.0,"shares_owned_after_display":"41,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-17","scope":"insider"},{"id":8821198,"accession":"0001140361-15-022847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-022847","line_url":"/filing/0001140361-15-022847#line-1","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":98.0,"shares_display":"98","price_per_share":27.08,"price_display":"27.08","price_state":"stated","total_value":2653.84,"total_display":"2,653.84","shares_owned_after":41444.0,"shares_owned_after_display":"41,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-02","scope":"insider"},{"id":6197065,"accession":"0001140361-14-012591","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-14-012591","line_url":"/filing/0001140361-14-012591#line-3","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11562.0,"shares_display":"11,562","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":317955.0,"total_display":"317,955.00","shares_owned_after":36145.0,"shares_owned_after_display":"36,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-12","filed_date":"2014-03-13","scope":"insider"},{"id":7028488,"accession":"0001140361-14-012346","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-14-012346","line_url":"/filing/0001140361-14-012346#line-6","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11820.0,"shares_display":"11,820","price_per_share":26.96,"price_display":"26.96","price_state":"stated","total_value":318667.2,"total_display":"318,667.20","shares_owned_after":36920.0,"shares_owned_after_display":"36,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-11","filed_date":"2014-03-12","scope":"insider"},{"id":7028487,"accession":"0001140361-14-012346","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-14-012346","line_url":"/filing/0001140361-14-012346#line-5","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, Biodefense Divison)","officer_title":"EVP, Biodefense Divison","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5835.0,"shares_display":"5,835","price_per_share":26.96,"price_display":"26.96","price_state":"stated","total_value":157311.6,"total_display":"157,311.60","shares_owned_after":36920.0,"shares_owned_after_display":"36,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-11","filed_date":"2014-03-12","scope":"insider"},{"id":8906914,"accession":"0001209191-11-017975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-017975","line_url":"/filing/0001209191-11-017975#line-2","is_derivative":false,"issuer_cik":"0001367644","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001367644","owner_cik":"0001514588","owner_name":"Havey Adam","owner_url":"/insider/0001514588","role":"Officer (EVP, BioDefense Division)","officer_title":"EVP, BioDefense Division","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":19.2,"price_display":"19.20","price_state":"stated","total_value":128006.4,"total_display":"128,006.40","shares_owned_after":4664.0,"shares_owned_after_display":"4,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-11","filed_date":"2011-03-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367644","name":"Emergent BioSolutions Inc.","url":"/issuer/0001367644","role":"Officer (EVP, Business Operations)","n_filings":22,"first_seen":"2011-03-15","last_seen":"2021-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001514588","retrieved_at":"2026-08-21T18:57:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}